Qixin Li

277 Yanta West Road
Xi'an, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

EZH2 deficiency suppresses colorectal cancer progression by inhibiting the mismatch repair pathway and consequently reducing extrachromosomal circular DNA formation.

EZH2 deficiency suppresses colorectal cancer progression by inhibiting the mismatch repair pathway and consequently reducing extrachromosomal circular DNA formation.

Journal: Cell death & disease
Published: January 17, 2026

Methyltransferase MGMT upregulation drives metastasis by activating epithelial-mesenchymal transition in KRAS mutant colon cancer.

Methyltransferase MGMT upregulation drives metastasis by activating epithelial-mesenchymal transition in KRAS mutant colon cancer.

Journal: Cell death & disease
Published: October 14, 2025

Correction to "Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis".

Correction to "Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis".

Journal: Molecular pharmaceutics
Published: June 03, 2025

Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis.

Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis.

Journal: Molecular pharmaceutics
Published: October 28, 2024

The association of appendectomy with prognosis and tumor-associated macrophages in patients with colorectal cancer.

The association of appendectomy with prognosis and tumor-associated macrophages in patients with colorectal cancer.

Journal: iScience
Published: March 09, 2024

Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancer.

Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancer.

Journal: Scientific reports
Published: October 12, 2023

MGMT activated by Wnt pathway promotes cisplatin tolerance through inducing slow-cycling cells and nonhomologous end joining in colorectal cancer.

MGMT activated by Wnt pathway promotes cisplatin tolerance through inducing slow-cycling cells and nonhomologous end joining in colorectal cancer.

Journal: Journal of pharmaceutical analysis
Published: September 13, 2023

Real-world analysis of survival benefit of surgery and adjuvant therapy in elderly patients with colorectal cancer.

Real-world analysis of survival benefit of surgery and adjuvant therapy in elderly patients with colorectal cancer.

Journal: Scientific reports
Published: April 27, 2023
Showing 1-8 of 8

Last Updated: 09/26/2026